Techniques in Regional Anesthesia & Pain Management
Volume 15, Issue 4 , Pages 147-149 , October 2011

Indications for intrathecal therapy in cancer patients

  • Jacqueline Lozano

      Affiliations

    • University at Buffalo, School of Medicine, Buffalo, New York
    • Corresponding Author InformationAddress reprint requests and correspondence: Jacqueline Lozano, University at Buffalo, School of Medicine, Buffalo, NY 14260
  • ,
  • Oscar A. de Leon-Casasola, MD

      Affiliations

    • Department of Anesthesiology, University at Buffalo, School of Medicine, Pain Medicine and Oncology, Roswell Park Cancer Institute, Buffalo, New York

References 

  1. Committee on Advancing Pain Research, Care, and Education; Institute of Medicine . Relieving pain in America: a blueprint for transforming prevention, care, education, and research (Institute of Medicine of the National Academies) . The National Academies Press; 2011; S5 http://www.nap.edu/catalog.php?record_id=13172 Accessed November 21, 2011
  2. Smith H . Definition and pathogenesis of chronic pain . http://www.uptodate.com/contents/definition-and-pathogenesis-of-chronic-pain?source=search_result&selectedTitle=2%7E150 Accessed July 16, 2011
  3. Deer T , Krames ES , Hassenbusch SJ , et al.  Polyanalgesic Consensus Conference 2007: recommendations for the management of pain by intrathecal (intraspinal) drug delivery: report of an interdisciplinary expert panel . Neuromodulation . 2007;10:300–328
  4. Deer TR , Smith HS , Burton AW , et al.  Comprehensive consensus based guidelines on intrathecal drug delivery systems in the treatment of pain caused by cancer pain . Pain Physician . 2011;14:E283–E312
  5. In:  Aliaga-Font L ,  de Leon-Casasola OA ,  Nebreda-Clavo CL , et al. editor. Intrathecal Therapy for Cancer Pain Management Barcelona, Spain: Editorial Glosa; 2011;p. 223–230
  6. Knight KH , Brand FM , Mchaourab AS , et al.  Implantable intrathecal pumps for chronic pain: highlights and updates . http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2080496/ Accessed July 16, 2011
  7. Smith TJ , Staats PS , Deer T , et al.  Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival . J Clin Oncol . 2002;20:4040–4049
  8. Smith TJ , Coyne PJ , Staats PS , et al.  An implantable drug delivery system (IDDS) for refractory cancer pain provides sustained pain control, less drug-related toxicity, and possibly better survival compared with comprehensive medical management (CMM) . Ann Oncol . 2005;16:825–833
  9. Liebeskind JC . Pain can kill . Pain . 1991;44:3–4
  10. Mayfield Clinic for Brain and Spine . Intrathecal Drug Pump . http://www.mayfieldclinic.com/PE-PUMP.htm Accessed July 16, 2011
  11. Staats PS , Yearwood T , Charapata SG , et al.  Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial . JAMA . 2004;291:63–70

PII: S1084-208X(11)00074-7

doi: 10.1053/j.trap.2011.10.002

Techniques in Regional Anesthesia & Pain Management
Volume 15, Issue 4 , Pages 147-149 , October 2011